To verify this hypothesis, we perform a model reaction between TPE-DCV and a thiol, 2-mercaptoethanol (ME)
less research for telogen effluvium specifically, but biological plausibility is strong
In clinical settings, the higher strength enables physicians to tailor treatment plans that are more aggressive yet manageable, particularly for patients who have not achieved desired results on lower doses
In brief, a fixed volume of plasma or serum (50 L) was spiked with internal standard
doi: 10.1210/jc.2017-02006 160 JensterleMFerjanSBattelinoTKovaJBattelinoSuputDet al
It requires clinical trials, in-depth review of both the safety and efficacy of each drug, and continuous monitoring afterward